Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Heron Therapeutics Inc (NASDAQ:HRTX)

32.34
Delayed Data
As of Jul 31
 +0.65 / +2.05%
Today’s Change
6.51
Today|||52-Week Range
36.81
+221.47%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization125.0K150.0K189.0K152.0K
 
 
 
 
 
 
Operating ExpensesGross Income-125.0K-150.0K-189.0K-152.0K
 
 
 
 
 
General Expenses18.7M18.8M19.3M20.2M
 
 
 
 
 
Research And Development14.4M14.7M14.2M14.5M
 
 
 
 
 
Total Operating Expenses18.8M19.0M19.5M20.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-18.8M-19.0M-19.5M-20.4M
 
 
 
 
 
Interest Expense On Debt220.0K241.0K--210.0K
 
 
 
 
Other Expenses0.000.00-1.1M0.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-19.0M-19.2M-20.6M-20.6M
 
 
 
 
 
Net Income-19.0M-19.2M-20.6M-20.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS24.3M29.0M29.2M29.4M
 
 
 
 
 
Shares To Calculate EPS Diluted24.3M29.0M29.2M29.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.78-$0.66-$0.71-$0.70
 
 
 
 
 
EPS Diluted-$0.78-$0.66-$0.71-$0.70